Papers/PMID:40375481
Quercetin Reduces Vascular Senescence and Inflammation in Symptomatic Male but Not Female Coronary Artery Disease Patients.
Aging cell2025The record
1 finding · 1 compound · 1 endpoint
What it reported
How to read these marksWhat moved
1 finding
quercetin — decreases postoperative atrial fibrillation incidence
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Finding“Post-operative atrial fibrillation incidence was significantly lower with quercetin, representing 4% of the patients compared to 18% in the placebo group (p = 0.033).”
Quoted verbatim from Quercetin Reduces Vascular Senescence and Inflammation in Symptomatic Male but Not Female Coronary Artery Disease Patients.. - Study
- RCT
- Dose
- 500 mg twice daily
- Population
- Patients undergoing coronary artery bypass graft surgery for coronary artery disease (78 men of 97), quercetin or placebo from two days pre-surgery through hospital discharge
Quercetin Reduces Vascular Senescence and Inflammation in Symptomatic Male but Not Female Coronary Artery Disease Patients.2025PMID:40375481Permalink